↓ Skip to main content

Dove Medical Press

Efficacy and tolerability of escitalopram in treatment of major depressive disorder with anxiety symptoms: a 24-week, open-label, prospective study in Chinese population

Overview of attention for article published in Neuropsychiatric Disease and Treatment, February 2017
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
53 Mendeley
Title
Efficacy and tolerability of escitalopram in treatment of major depressive disorder with anxiety symptoms: a 24-week, open-label, prospective study in Chinese population
Published in
Neuropsychiatric Disease and Treatment, February 2017
DOI 10.2147/ndt.s120190
Pubmed ID
Authors

Kaida Jiang, Lingjiang Li, Xueyi Wang, Maosheng Fang, Jianfei Shi, Qiuyun Cao, Jincai He, Jinan Wang, Weihao Tan, Cuili Hu

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 53 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 13%
Student > Master 6 11%
Other 5 9%
Student > Bachelor 4 8%
Student > Doctoral Student 3 6%
Other 10 19%
Unknown 18 34%
Readers by discipline Count As %
Medicine and Dentistry 10 19%
Nursing and Health Professions 6 11%
Pharmacology, Toxicology and Pharmaceutical Science 5 9%
Psychology 3 6%
Agricultural and Biological Sciences 2 4%
Other 7 13%
Unknown 20 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 May 2024.
All research outputs
#15,213,229
of 25,830,657 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,364
of 3,151 outputs
Outputs of similar age
#223,782
of 427,566 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#37
of 74 outputs
Altmetric has tracked 25,830,657 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,151 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 427,566 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 74 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.